PenCLAHRC, National Institute for Health Research, Plymouth University Peninsula Schools of Medicine and Dentistry, Devon, United Kingdom.
Health Policy. 2013 Oct;112(3):197-201. doi: 10.1016/j.healthpol.2013.06.012. Epub 2013 Jul 30.
In 2003, The National Health Service Cervical Screening Programme (NHSCSP) in England modified its recommendation by increasing the age at which to begin screening from 20 to 25. This was on the grounds that normal changes in the cervix before the age of 25 are often identified during screening as being abnormal, resulting in many young women receiving unnecessary treatment at both a significant psychological cost to the patient and a financial cost to the service. In 2011, the cervical screening programme in Northern Ireland was also amended followed closely by Scotland in late 2012. Some 10 years later, Wales finally altered cervical screening policy in January 2013 and now invite women for an initial screen at the age of 25, in line with the rest of the United Kingdom (UK). The withdrawal of cervical screening from 20 to 24 years in England was the first occasion globally, where a population cancer screening programme was withdrawn. Although the changes in England were perceived by some as "rational care" - as they encourage utilisation of beneficial services while discouraging use of those that may lead to more harms than benefits, many people also believe them to be "rationing care". In fact, even now, a decade on from the policy alterations in England, people are still vociferously exhibiting their discontent at the decision; exacerbated by national media headlines such as: "Denying young women smear tests is a disgrace". Yet with recent, rather alarming analysis of trends in England suggesting a rise in the incidence of cervical cancer in young women, it seems of great public health interest to consider whether such a rise is attributable to reduced cervical screening activity and reflect on whether the decision to alter cervical screening policy for those under the age of 25 was, in fact, a rational and correct decision.
2003 年,英格兰国家医疗服务体系(NHS)宫颈筛查计划(NHSCSP)修改了其建议,将开始筛查的年龄从 20 岁提高到 25 岁。这是因为在 25 岁之前,宫颈的正常变化通常在筛查中被识别为异常,导致许多年轻女性在接受不必要的治疗,这不仅对患者造成巨大的心理负担,也给服务带来经济负担。2011 年,北爱尔兰的宫颈筛查计划也进行了修改,紧随其后的是 2012 年末的苏格兰。大约 10 年后,威尔士终于在 2013 年 1 月改变了宫颈筛查政策,现在邀请女性在 25 岁时进行初次筛查,与联合王国(UK)的其他地区保持一致。英格兰将宫颈筛查从 20 岁降至 24 岁,这是全球范围内首次取消人群癌症筛查计划。尽管英格兰的这些变化被一些人视为“合理护理”——因为它们鼓励利用有益的服务,同时不鼓励使用那些可能弊大于利的服务,但许多人也认为这是“限制护理”。事实上,即使在英格兰政策调整十年后的今天,人们仍然强烈表达对这一决定的不满;再加上英国媒体的头条新闻,如:“拒绝年轻女性巴氏涂片检查是一种耻辱”。然而,最近对英格兰趋势的分析相当令人震惊,表明年轻女性宫颈癌的发病率有所上升,因此,考虑这种上升是否归因于宫颈筛查活动的减少,并反思将 25 岁以下人群的宫颈筛查政策改变的决定是否合理和正确,这对于公共卫生具有重要意义。